510(k) K260447
K260447 is an FDA 510(k) premarket notification submitted by bioMérieux SA for the device "ETEST Gepotidacin (GEP) (0.016-256 µg/mL)". The FDA issued a decision of Substantially Equivalent on April 21, 2026. The device falls under product code JWY (Manual Antimicrobial Susceptibility Test Systems), a Class II device regulated under 21 CFR 866.1640. bioMérieux SA has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 21, 2026
- Date Received
- February 11, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Manual Antimicrobial Susceptibility Test Systems
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type